RecruitingPhase 2NCT06446245
Adjunctive Doxycycline for Central Nervous System Tuberculosis
Studying Central nervous system tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National University Hospital, Singapore
- Intervention
- Doxycycline(drug)
- Enrollment
- 200 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2025 – 2027
Study locations (5)
- Adam Malik Hospital, Medan, Indonesia
- Universitas Sumatera Utara, Medan, Indonesia
- Sarawak General Hospital, Kuching, Sarawak, Malaysia
- National University Hospital, Singapore, Singapore
- Tan Tock Seng Hospital, Singapore, Singapore
Collaborators
National Medical Research Council (NMRC), Singapore
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06446245 on ClinicalTrials.govOther trials for Central nervous system tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06338215Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and MortalityClinica Universidad de Navarra, Universidad de Navarra
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06811025Phase II Clinical Study of Contezolid for the Treatment of Tuberculous MeningitisBeijing Chest Hospital